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Millions of coronary angiograms are performed annually to obtain information that, when combined with clinical data, guides treatment decisions for patients with coronary artery disease. 1 These tests are performed, in large part, to determine the presence and severity of coronary stenoses, which in turn plays a key role in selection of patients for revascularization. 2 In clinical practice, stenosis severity is typically determined during or shortly after the procedure, and most commonly relies on visual estimation by physicians. This approach, however, has wellknown limitations. 3, 4 Older studies, conducted a decade or more ago, described interobserver and intraobserver variation in visual estimations of stenosis severity and inaccuracies when compared with computer-assisted techniques, expert panel review, autopsy results, or simulations. [5] [6] [7] [8] [9] [10] [11] [12] [13] Despite the potential implications of these findings -particularly regarding the consistency and quality of treatment decisions for revascularization 13 -no widespread efforts have been undertaken to improve clinical interpretations of coronary angiograms nor has there been further study of the issue.
We lack contemporary information about the quality of clinical interpretations of coronary angiograms. Since studies were last performed in the early 1990s, significant advances in digital technology have transformed angiographic imaging. 14 Whether this has led to concomitant improvements in clinical interpretations is largely uncertain, however.
Understanding this issue is relevant given that stenosis severity, as assessed by physicians, remains a pivotal variable for framing treatment options -even in the current era where pre-or intra-procedural functional testing of a stenosis is widely available. Moreover, the percent diameter stenosis continues to be used as an entry criterion for clinical trials of revascularization and its reliable measurement is a key assumption of current Appropriateness Use Criteria for revascularization. 15 Errors in the clinical interpretation of coronary angiograms therefore have Despite the potential implications of these findings -particularly regarding the c co on onsi si s st ten en ency cy cy a a an nd quality of treatment decisions for revascularization 13 -no widespread efforts have been un nde de dert rt rtak ak aken en en t t to o o im m mpr pr prov o e clinical interpretations of f f c co or ronary angiog g gra r r ms ms n n no o or has there been further t tud d dy y of the iss ssu ue e.
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To explore the quality of clinical interpretation in the modern era of interventional cardiology, we designed the Assessing Angiography (A2) project. We randomly selected coronary angiograms from patients undergoing percutaneous coronary intervention (PCI) at seven large US hospitals. The clinical interpretation of stenosis severity among lesions with PCI by physicians was compared with measurements made by an independent, blinded review using state-of-the-art quantitative coronary angiography (QCA) -a computer-assisted technique for measuring stenosis severity employed for decades for quality assurance within clinical trials. 16 We purposely selected QCA as a benchmark tool given its high reproducibility and potential freedom from observer influence and bias. 17 
Methods

Data Sources and Clinical Abstraction
We enrolled seven PCI hospitals participating in the CathPCI Registry ® of the National Cardiovascular Data Registry ® (NCDR ® ), sponsored by the American College of Cardiology (ACC) and the Society for Cardiovascular Angiograpy and Intervention (SCAI). We selected sites for this study to ensure diversity in regional location. We only included sites that had digital storage capability and could transfer coronary angiograms digitally for further assessment and interpretation. The Aetna Foundation provided funding for the study. The investigators were responsible for all data collection and analyses, as well as the decision to publish the findings.
The study was initially designed to produce information that could be used for a future quality improvement initiative by initiating feedback to participating hospitals on the correlation of their We purposely selected QCA as a benchmark tool given its high reproducibility an an nd d po po ote te ent nt ntia ia ial l l freedom from observer influence and bias. 17
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We enrolled se se seve ve v n n n PC PC PCI I ho hosp sp spit it ital l ls s s pa pa part rt r ic c cip ip ipat at atin in ing g g in in i t the he he C Cat at athP hP hPCI CI C R R Reg eg e is is str tr try y y ® ® ® o o of f f th th t e e e Na Na Nati ti ion on onal by guest on April 13, 2017 http://circ.ahajournals.org/ Downloaded from clinical interpretation of coronary angiograms with QCA from a core laboratory. When a decision to publish these findings was made, we obtained approval from the Institutional Review Board of the Saint Luke's Hospital (Kansas City, Missouri) where analyses were conducted as an exempted study, since all data were de-identified at this point.
From each of the hospitals, we obtained coronary angiograms on patients who underwent PCI during calendar year 2011. Data managers at the NCDR generated a random list of patients at each hospital after excluding patients undergoing PCI for urgent or emergency indications. For each patient, we obtained the clinical report of the coronary angiogram and catheterization laboratory log, after they were stripped of all unique patient identifiers, as well as a de-identified digital copy of the coronary angiogram. Data abstracted directly from the clinical records (not the CathPCI Registry) included information on: catheter size, lesion location, maximal percent diameter stenosis before and after PCI, and use of fractional flow reserve (FFR). In cases where multiple lesions were described and treated, we abstracted data pertaining to each lesion. We obtained supplemental information on the clinical characteristics and presentation of each patient from each site as part of the data that they routinely collected and provided to the CathPCI Registry.
Quantitative Coronary Angiography
The de-identified clinical records and angiograms were managed by ImageCor, LLC (Bradenton, 
Data Analysis
We used univariate statistics to describe the study population. We then used a lesion-specific approach to compare the percent diameter stenosis by the two methods of assessment and this was expressed as the difference between the clinical interpretation and QCA using Student ttests. Concordance was further analyzed using 2 quantitative methods. First, we evaluated the he site of minimal lumen diameter and derived by an iterative linear regression t te tech ch hni ni iqu qu que e e th th that at is operator independent and accounts for vessel tapering. 18, 19 The minimal lesion diameter was used h he e e si si ing ng ngle le-b -b bes e est, t, a a ava a ail ila ab ble le e p pro oje je ject ct ctio io ion n n wi wi ith th h l l lea ea east t t f f for or re es sh ho or orte te eni ni ning ng ng t t tha ha at be be best st de e emo mo ons ns str tr t at at ted ed ed th h he s ste ten no nosi si s s analysis. Second, we categorized percent diameter stenosis from two methods according to the following cutoffs: <50%, 50 to <70%, 70 to <90%, 90 to <100%, and 100% (but explored additional cutoffs in sensitivity analyses). We then assessed concordance between clinical interpretation and QCA using Cohen's weighted kappa statistic, 20 a statistical measure of interrater agreement for categorical items. The kappa statistic is generally considered a more robust measure than a simple percent agreement calculation, since it considers agreement occurring by chance. Because the kappa statistic takes the observed categories' frequencies as givens, it may underestimate agreement for a category that is also commonly used. Given this concern, the kappa statistic is considered an overly conservative measure of agreement. 21 We also performed subgroup analyses. We first repeated our analyses after excluding patients with lesions thought to be associated with a recent non-ST elevation myocardial infarction or within coronary artery bypass grafts, since the thresholds for revascularization based on percent diameter stenosis may be different in these circumstances. We also examined variation in angiographic interpretation across differences in stenosis severity, lesion location in the coronary vasculature, lesion reference vessel diameter, lesion length, quality of the coronary angiogram determined by the core laboratory, presence of a stress test or FFR, and individual hospital sites.
The sample size for this study was difficult to estimate, given the study's intent to generate basic descriptive information about agreement between clinical interpretations and QCA. We proposed to collect 25 studies from each of eight hospitals, and seven hospitals ultimately participated in the quality improvement initiative. All analyses were conducted with SAS (Version 9.3) and R (Version 2.15.0) software.
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Results
Study Population
The study sample included 175 patients who underwent PCI of 228 lesions at the 7 sites. A list of baseline characteristics is displayed in Table 2 lists characteristics associated with the 228 lesions that were treated by PCI in the study population. Most treated lesions were in the left anterior descending coronary artery followed by the right coronary artery and left circumflex coronary artery. There were 16 FFR assessments performed, of which 13 were abnormal with values less than or equal to 0.80. In 216 lesions, a clinical interpretation with percent diameter stenosis was available while the remaining 12 lesions were reported in qualitative terms (e.g., "severe" or "critical") ( Table 2 ). These 12
were excluded from analyses evaluating concordance.
Of the 216 lesions treated with PCI where stenosis severity by clinical interpretation was reported, median percent diameter stenosis was 80.0% (first and third quartiles, 80 and 90%) and mean percent diameter stenosis was 84.2% (± 10.1). The most commonly reported percent diameter stenoses were in the range of 70 to <90% followed by 90 to <100%. In only 3 (1.4%) lesions was the percent diameter stenosis reported to be <70% by clinical interpretation; a stress test was documented (although information on specific results is unavailable) and/or an FFR was performed in these 3 patients. No lesion was reported to be <50%. 
Comparison of Clinical Interpretation and QCA
QCA was performed in all 228 lesions treated with PCI with a median percent diameter stenosis of 74.6% (first and third quartiles, 69.5 and 82.5%) and mean percent diameter stenosis was 76.1% (± 10.9). Similar to clinical interpretation, the most commonly calculated percent diameter stenosis was in the range of 70 to <90% ( Table 2 ). The next most frequent category of stenosis severity by QCA was 50 to <70% with 61 (26.8%) lesions in this category; of these, 35
(57.4%) had documentation of stress testing or FFR before PCI, and rates of stress testing did not vary across categories of stenosis severity (see Supplemental Table 1 ). No lesion was calculated to be <50% by QCA. There was no significant difference by QCA between the 12 lesions where stenosis severity by clinical interpretation was reported in qualitative terms (e.g., "severe" or "critical") and others (77.4% versus 76.0%; p=0.66).
The mean difference in percent diameter stenosis between the clinical interpretation and QCA was +8.2% ± 8.4% (n=216), reflecting an average higher percent diameter stenosis by the clinical interpretation (P<0.001). The distribution of this difference across the lesions is shown in Figure 1 . Of the 213 lesions considered 70% or greater by clinical assessment, 56 (26.3%) were measured at less than 70% by QCA and 10 (4.7%) were less than 60%.
A scatter plot of the clinical interpretation and quantitative assessment by QCA is displayed in Figure 2 , demonstrating a Pearson correlation coefficient of 0.68. Clinical interpretations had a discrete distribution with most of the reported values being divisible by 10% (e.g., 70%, 80%, etc.) while QCA stenoses were continuously distributed. tenosis severity by clinical interpretation was reported in qualitative terms (e.g., ., " "se se sev ve ere e re" " " or or or "critical") and others (77.4% versus 76.0%; p=0.66). Our findings were essentially unchanged when we repeated our analyses after excluding patients with lesions associated with non-ST elevation myocardial infarction or within coronary artery bypass grafts (see Supplemental Tables 2 and 3 ; Supplemental Figures 1 and 2) .
Finally, we found the mean difference in percent diameter stenosis between the clinical interpretation and QCA was greatest for lesions between 50 to <70% by QCA, but diminished with higher stenosis severity ( Table 4 ). Less variation in the mean difference in percent diameter stenosis between the 2 methods was noted across several other subgroups ( Table 4) , with the exception of variation across individual hospital sites that ranged from 5.6% to 11.2% (Figure   3 ). Using alternative cutoffs to categorize lesions by percent diameter stenosis from two methods did not lead to substantial differences in our results (Supplemental Table 4 ).
Discussion
We found significant differences between the percent diameter stenosis of a lesion as assessed by clinical interpretation and QCA in patients undergoing PCI at seven U.S. hospitals. In general, the clinical interpretation by physicians was 70% or greater in most treated lesions, whereas approximately a quarter of the measurements by QCA were below that level. However, the extent of differences was +8% on average and no lesion was less than 50% by QCA. Overall, findings from our study suggest potential opportunities for improving the clinical interpretation of coronary angiograms in routine practice, and thus, optimizing the selection and care of patients considered for revascularization.
The clinical value of any imaging test depends upon several factors, including acquisition and interpretation of the images and incorporation of this information into clinical decisionmaking. Despite many technical advances that have transformed the ways in which image did not lead to substantial differences in our results (Supplemental Table 4 ).
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We acquisition now occurs with coronary angiography, little work has been done on developing strategies for improving its interpretation over the years. Indeed, interpretation may be even more challenging today as more decisions about revascularization are made during or just after the procedure is performed, in order to maximize efficiency and minimize costs (i.e., ad hoc PCI). 22 This may limit what formerly occurred through collective discussions (e.g., "cath conference"), despite earlier evidence that "group" reads significantly improves the accuracy of interpretations. 23, 24 Thus, our findings of the inconsistency between the clinical interpretation and an independent measurement by QCA, particularly for lower severity stenoses, raise concerns.
Despite its limitations, newer-generation systems of QCA have high reproducibility and
precision in quantifying stenosis severity even in complex lesions, 25 Providing feedback to hospitals also may be useful for improving clinical interpretation, as we did notice facility-level variation in the mean difference in percent diameter stenosis Despite its limitations, newer-generation systems of QCA have high reproducibi bil li lity ty y and nd nd precision in quantifying stenosis severity even in complex lesions, 25 which has contributed its wi wide de desp sp spre read ad ad u us se i i in n n cl clinical trials of revascularizat at atio io i n n n. Although di iff ff f eren en nce ce ces between the clinical n nte e erp rpretation a and nd n Q QCA CA C i i in n n an an an i i iso sola la ate te ed d pa pa atien n nt s shou u ul ld d n nev ev ever er b be e e co co ons sid ider er red d d a an n n a au auto toma ma mati ti tic c "f f fl la lag" g" g f for 27, 28 Moreover, some of these providers have consistently reported better than expected outcomes, 29 since treating mild coronary artery disease is almost always safe for patients, despite providing little benefit. This underscores the limitations of quality assurance tools that focus largely on chart abstraction and assessing complications.
Challenges exist when considering the potential next steps that may result from our findings. New approaches need to be developed for improving clinical interpretation through innovative educational initiatives or quality assurance programs. Given its potential scalability, QCA may offer be an efficient method for achieving these objectives, but this is unknown. In particular, it is necessary to examine how QCA or other methods to improve clinical interpretation may be integrated into the busy workflow of interventional cardiology. This must be done in a critical and rigorous manner, as the addition of such tools does not necessarily result in improvement. For example, data on the clinical value of computer-assisted screening mammography in routine practice have been mixed. 30, 31 Our study should be interpreted in the context of the following limitations. First, we only examined patients undergoing PCI. We did not perform QCA in lesions that were considered outcomes, 29 since treating mild coronary artery disease is almost always safe for r pa pa pati ti t en en nts ts ts, , , de de desp spite providing little benefit. This underscores the limitations of quality assurance tools that focus a arg rg gel el ely y y on on n c c cha ha h rt a a ab bs bstr t action and assessing compl l li ic ica at tions.
Challe eng nges es s e exi xi xist t w whe he hen n n co con ns nsid id i e er ri in ng th th he e e pot te ten ntia clinically insignificant or managed medically or surgically; our findings are not relevant to those settings, which will require additional investigations. Second, QCA itself has limitations. As such, this study was focused specifically on assessing the quality of the clinical interpretation of the coronary angiogram, not the appropriateness of the clinical decision to intervene. For example, QCA does not include information on the hemodynamic significance of a stenosis. In isolation, it does not account for many factors that should influence clinical decisions on revascularization nor does it alone predict long-term outcomes after treatment. 32 Nevertheless, accurate assessment of stenosis severity is essential for physicians and patients, as this remains
arguably the most critical factor in practical, day-to-day decisions about revascularization. Even current Appropriateness Use Criteria that emphasize the importance of symptoms and functional testing assume the presence of a "significant" stenosis of "greater than or equal to 70% luminal diameter narrowing, by visual assessment" prior to revascularization. Of course, future work will need to tie findings such as ours directly to clinical decisions and outcomes.
Third, calculating stenosis severity by QCA still requires satisfactory image acquisition and minimal user input to identify imaging frames for analysis, which may introduce variability as well. For this reason, our assessments were performed using analysts blinded to the clinical interpretation and at a core laboratory with broad experience in regulatory studies involving QCA. Fourth, our study was limited to 7 hospitals. These were primarily high-volume and recognized PCI centers, and importantly, each volunteered to participate as part of a pilot quality improvement initiative. Whether our findings are applicable to a more broadly representative group of hospitals is uncertain, though the results may represent a best-case scenario. In conclusion, we found that physicians tended to assess lesions treated by PCI as more severe than measurements by QCA. Findings from our study are consistent with older work and suggest possible opportunities to further improve clinical interpretation of coronary angiography and optimize the selection and care of patients undergoing PCI in contemporary practice.
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